Loading...
•
Mar 31, 2020
Utah Medical Q1 2020 Earnings Report
Results consistent with 1Q 2019 were attained despite negative impact from COVID-19.
Key Takeaways
Utah Medical Products, Inc. reported a slight increase in revenues and gross profit for the first quarter of 2020 compared to the same period in 2019, but experienced a decrease in operating income due to higher amortization expenses and the impact of COVID-19 on elective surgeries.
Total consolidated sales increased by 1.6% compared to 1Q 2019.
U.S. domestic sales were 11% higher, while OUS sales were 10% lower.
Operating income decreased by 5.8% due to higher amortization expenses.
The company repurchased 80,000 shares in the open market and paid cash dividends to stockholders.
Revenue by Geographic Location
Forward Guidance
Management estimates that 2Q 2020 consolidated revenues may be two-thirds of 2Q 2019 revenues due to uncertainty regarding hospital elective procedures and patient confidence.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...